Novel Reagent Generation for Cancer and Stem Cell Cultures

用于癌症和干细胞培养的新型试剂生成

• 批准号: 521164-2017
• 负责人: Arrowsmith, Cheryl
• 金额: $ 1.82万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Engage Grants Program
• 财政年份: 2017
• 资助国家: 加拿大
• 起止时间: 2017-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=640226
• 关键词: Novel; Reagent; Generation; Cancer; Stem

Custom Biologics is a global service provider for developing, validating and implementing cell-based, ligand-binding andbioanalytical pharmacokinetic bioassays to support the drug development testing requirements of biotherapeutics and smallmolecules. Our assay development and regulatory compliant assay validation services have supported drug developmentprograms of over 50 pharmaceutical companies world wide. The proposed project will focus on developing a procedure to scalecytokine and growth factor production to a GMP controlled environment to be commercially available. Custom Biologics will becollaborating with Professor Arrowsmith, the Chief Scientist of the Structural Genomics Consortium (SGC) at the University ofToronto.

Custom Biologics是一家全球服务提供商，致力于开发、验证和实施基于细胞的、配体结合和生物分析药代动力学生物测定，以支持生物治疗药物和小分子的药物开发测试要求。我们的分析开发和符合法规的分析验证服务已支持全球50多家制药公司的药物开发计划。拟议的项目将侧重于开发一种程序，以在GMP控制的环境中生产可商业化的趋化因子和生长因子。Custom Biologics将与多伦多大学结构基因组学联盟（SGC）的首席科学家Arrowsmith教授合作。